Cargando…
Correction to: Efficacy and safety of tetramethylpyrazine phosphate on pulmonary hypertension: study protocol for a randomized controlled study
Autores principales: | Chen, Yuqin, He, Wenjun, Ouyang, Haiping, Liu, Chunli, Hong, Cheng, Wang, Tao, Yang, Kai, Lu, Wenju, Wang, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104479/ https://www.ncbi.nlm.nih.gov/pubmed/32228673 http://dx.doi.org/10.1186/s13063-020-04245-x |
Ejemplares similares
-
Efficacy and safety of tetramethylpyrazine phosphate on pulmonary hypertension: study protocol for a randomized controlled study
por: Chen, Yuqin, et al.
Publicado: (2019) -
Correction to: Prediction and prognosis of adverse maternal and foetal/neonatal outcomes in pulmonary hypertension: an observational study and nomogram construction
por: Chen, Yuqin, et al.
Publicado: (2023) -
Evaluation of Antioxidant and Immunity Function of Tetramethylpyrazine Phosphate Tablets in Vivo
por: Guo, Ling, et al.
Publicado: (2012) -
Potential biomarkers and therapeutic targets of idiopathic pulmonary arterial hypertension
por: He, Wenjun, et al.
Publicado: (2022) -
BET Signaling: A Novel Therapeutic Target for Pulmonary Hypertension?
por: Chen, Lingdan, et al.
Publicado: (2020)